Could Pyelonephritic Scarring Be Prevented by Anti-Inflammatory Treatment? An Experimental Model of Acute Pyelonephritis
Figure 1
(a) DMSA kidney scintigraphy that indicates normal activity retention in the 3rd day in control group (pyelonephritis score: 0). (b)DMSA kidney scintigraphy in the 3rd day in ceftriaxone group (pyelonephritis score: 1). (c) DMSA kidney scintigraphy in the 3rd day in ceftriaxone-ketoprophen group (pyelonephritis score: 3). (d) DMSA kidney scintigraphy in the 10th week in no-treatment group (scar score: 2). (e) DMSA kidney scintigraphy in the 10th week in ceftriaxone group (scar score: 1). (f) DMSA kidney scintigraphy in the 10th week in Ceftriaxone − Ketoprophen Group (scar score: 0).
